Brought to you by 
Pfizer ups offer for AstraZeneca to $84.19 per share; AZ board not interested
30 May 2014
Executive Summary
After proposing to pay $78.48 (£46.61) back in January, Pfizer Inc. upped its offer for AstraZeneca PLC to $84.19 per share--a 17% discount based on the original bid date and 43% based on the current market average--valuing the transaction at $106bn.
Deal Industry
- Pharmaceuticals
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pfizer ups offer for AstraZeneca to $84.19 per share; AZ board not interested
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice